EMEA-001990-PIP01-16-M02

Key facts

Active substance
Fenfluramine (hydrochloride)
Therapeutic area
Neurology
Decision number
P/0354/2018
PIP number
EMEA-001990-PIP01-16-M02
Pharmaceutical form(s)
Oral solution
Condition(s) / indication(s)
Treatment of Dravet syndrome
Route(s) of administration
  • Oral use
  • Gastric use
Contact for public enquiries
Zogenix International Ltd

Tel. +44 (0)7900 626263
E-mail: jwatson@zogenix.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating